Recent advances in inhibitors of sirtuin1/2: an update and perspective.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Future Medicinal Chemistry

• Publication date

  2018-04-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4155/fmc-2017-0207PMID 29642711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiproliferative S-Trityl-l-Cysteine -Derived Compounds as SIRT2 Inhibitors: Repurposing and Solubility Enhancement

  2019cited by this paper
• The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets

  2018cited by this paper
• SIRT3 knockdown increases oxidative stress and sensitivity to cytotoxic treatments in SW620 cancer cells

  2017cited by this paper
• Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity.

  2017cited by this paper
• Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity

  2017cited by this paper
• Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis

  2017cited by this paper
• SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.

  2017cited by this paper
• SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection

  2017cited by this paper
• Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis

  2017cited by this paper
• Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice

  2017cited by this paper
• NAD+ dependent deacetylase Sirtuin 5 rescues the innate inflammatory response of endotoxin tolerant macrophages by promoting acetylation of p65.

  2017cited by this paper
• Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.

  2017cited by this paper
• Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3'-indoline]-2',4(3H)-diones and their evaluation for anticancer activity.

  2017cited by this paper
• Betulinic acid derivative B10 inhibits glioma cell proliferation through suppression of SIRT1, acetylation of FOXO3a and upregulation of Bim/PUMA.

  2017cited by this paper
• Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).

  2017cited by this paper
• Effect of sodium salt of Butrin, a novel compound isolated from Butea monosperma flowers on suppressing the expression of SIRT1 and Aurora B kinase-mediated apoptosis in colorectal cancer cells.

  2017cited by this paper
• Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, “selectivity pocket” and NAD+-binding site

  2017cited by this paper
• A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53.

  2017cited by this paper
• Design, synthesis and anticancer activity of N-(1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl derivatives.

  2017cited by this paper
• Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket

  2017cited by this paper
• KH-TFMDI, a novel sirtuin inhibitor, alters the cytoskeleton and mitochondrial metabolism promoting cell death in Leishmania amazonensis

  2017cited by this paper
• Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model

  2017cited by this paper
• Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.

  2016cited by this paper
• 5-Benzylidene-hydantoin is a new scaffold for SIRT inhibition: From virtual screening to activity assays.

  2016cited by this paper
• SIRT2 Reverses 4-Oxononanoyl Lysine Modification on Histones.

  2016cited by this paper
• SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models.

  2016cited by this paper
• 1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors

  2016cited by this paper
• Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor

  2016cited by this paper
• Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins*

  2016cited by this paper
• SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms

  2016cited by this paper
• 5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.

  2016cited by this paper
• Javamide-I-O-methyl ester increases p53 acetylation and induces cell death via activating caspase 3/7 in monocytic THP-1 cells.

  2016cited by this paper
• Structure-Based Development of an Affinity Probe for Sirtuin 2.

  2016cited by this paper
• Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels.

  2016cited by this paper
• Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties

  2015cited by this paper
• The histone deacetylase sirtuin 2 is a new player in the regulation of platelet function

  2015cited by this paper
• Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts

  2015cited by this paper
• New indole-isoxazolone derivatives: Synthesis, characterisation and in vitro SIRT1 inhibition studies.

  2015cited by this paper
• LEADOPT: an automatic tool for structure-based lead optimization, and its application in structural optimizations of VEGFR2 and SYK inhibitors.

  2015cited by this paper
• Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity.

  2015cited by this paper
• The Discovery of a Highly Selective 5,6,7,8‐Tetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson’s Disease Model

  2015cited by this paper
• Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.

  2015cited by this paper
• Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.

  2015cited by this paper
• Selective Sirt2 inhibition by ligand-induced rearrangement of the active site

  2015cited by this paper
• Efficient Demyristoylase Activity of SIRT2 Revealed by Kinetic and Structural Studies

  2015cited by this paper
• AK-1, a specific SIRT2 inhibitor, induces cell cycle arrest by downregulating Snail in HCT116 human colon carcinoma cells.

  2015cited by this paper
• Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.

  2015cited by this paper
• Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.

  2015cited by this paper
• An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.

  2015cited by this paper
• Identification of ‘erasers’ for lysine crotonylated histone marks using a chemical proteomics approach

  2014cited by this paper
• Synthesis and biological evaluation of coumarin–1,2,3-triazole–dithiocarbamate hybrids as potent LSD1 inhibitors

  2014cited by this paper
• Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.

  2014cited by this paper
• Structural basis for potent inhibition of SIRT2 deacetylase by a macrocyclic peptide inducing dynamic structural change.

  2014cited by this paper
• Sorting out functions of sirtuins in cancer

  2014cited by this paper
• Lysine glutarylation is a protein posttranslational modification regulated by SIRT5.

  2014cited by this paper
• Chemistry: Chemical con artists foil drug discovery

  2014cited by this paper
• Tenovin-D3, a Novel Small-Molecule Inhibitor of Sirtuin SirT2, Increases p21 (CDKN1A) Expression in a p53-Independent Manner

  2013cited by this paper
• Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress

  2013cited by this paper
• Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects.

  2013cited by this paper
• The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.

  2013cited by this paper
• Crystal structure analysis of human Sirt2 and its ADP-ribose complex.

  2013cited by this paper
• NAD+ metabolism: A therapeutic target for age-related metabolic disease

  2013cited by this paper
• Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins* ♦

  2013cited by this paper
• Inhibition of the human deacylase Sirtuin 5 by the indole GW5074.

  2013cited by this paper
• Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7.

  2013cited by this paper
• Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.

  2013cited by this paper
• Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine

  2013cited by this paper
• An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms

  2013cited by this paper
• Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS.

  2012cited by this paper
• The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.

  2012cited by this paper
• A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53

  2012cited by this paper
• SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

  2012cited by this paper
• Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5.

  2012cited by this paper
• Discovery and Validation of SIRT2 Inhibitors Based on Tenovin-6: Use of a 1H-NMR Method to Assess Deacetylase Activity

  2012cited by this paper
• Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors

  2012cited by this paper
• Medicinal chemistry of sirtuin inhibitors.

  2011cited by this paper
• Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008

  2011cited by this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cited by this paper
• Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).

  2010cited by this paper
• Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).

  2010cited by this paper
• Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

  2009cited by this paper
• Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells

  2009cited by this paper
• Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.

  2009cited by this paper
• N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.

  2009cited by this paper
• Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majuscula.

  2009cited by this paper
• Thiobarbiturates as Sirtuin Inhibitors: Virtual Screening, Free‐Energy Calculations, and Biological Testing

  2008cited by this paper
• Phloroglucinol derivatives guttiferone G, aristoforin, and hyperforin: inhibitors of human sirtuins SIRT1 and SIRT2.

  2007cited by this paper
• Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins)

  2007cited by this paper
• Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1*

  2007cited by this paper
• Regulation of Insulin Secretion by SIRT4, a Mitochondrial ADP-ribosyltransferase*

  2007cited by this paper
• SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress.

  2007cited by this paper
• Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.

  2006cited by this paper
• 2‐Anilinobenzamides as SIRT Inhibitors

  2006cited by this paper
• Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.

  2006cited by this paper
• SIRT1 Regulates HIV Transcription via Tat Deacetylation

  2005cited by this paper
• Mechanism of Human SIRT1 Activation by Resveratrol*

  2005cited by this paper
• Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

  2005cited by this paper
• Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.

  2005cited by this paper
• Inhibitors of Sir2: evaluation of splitomicin analogues.

  2004cited by this paper
• Medicinal chemistry and pharmacology of cyclic ADP-ribose.

  2004cited by this paper

• A Review on Indole-triazole Molecular Hybrids as a Leading Edge in Drug Discovery: Current Landscape and Future Perspectives.

  2024cites this paper
• Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease

  2024cites this paper
• Targeting SIRT2 in Aging-Associated Fibrosis Pathophysiology

  2024cites this paper
• Tenovin-1, a Selective SIRT1/2 Inhibitor, Attenuates High-fat Diet-induced Hepatic Fibrosis via Inhibition of HSC Activation in ZDF Rats

  2024cites this paper
• Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives.

  2023cites this paper
• Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery

  2023influential citation
• 5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs

  2023cites this paper
• Discovery and design of dual inhibitors targeting Sphk1 and Sirt1

  2023cites this paper
• A therapeutically targetable NOTCH1-SIRT1-KAT7 axis in T-cell Leukemia

  2022cites this paper
• Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option

  2022cites this paper
• Sirtuins and the hallmarks of cancer

  2021cites this paper
• The study of sirtuins in breast cancer patients before and after radiotherapy

  2021cites this paper
• In Vitro Validation of Network Pharmacology Predictions: Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Cell Proliferation via SIRT2

  2021cites this paper
• Medicinal chemistry of histone deacetylase inhibitors

  2021influential citation
• p53 regulated senescence mechanism and role of its modulators in age-related disorders.

  2021cites this paper
• Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation.

  2021cites this paper
• Rational design and development of HDAC inhibitors for breast cancer treatment.

  2021cites this paper
• The literature of heterocyclic chemistry, part XVIII, 2018

  2020cites this paper
• The Versatility of Sirtuin-1 in Endocrinology and Immunology

  2020cites this paper
• Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence

  2020cites this paper
• Novel SIRT Inhibitor, MHY2256, Induces Cell Cycle Arrest, Apoptosis, and Autophagic Cell Death in HCT116 Human Colorectal Cancer Cells

  2020influential citation
• Structure activity study of S-trityl-cysteamine dimethylaminopyridine derivatives as SIRT2 inhibitors: Improvement of SIRT2 binding and inhibition.

  2020cites this paper
• Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1H-Purine-2,6-Diones as Potent Inhibitors of SIRT1, SIRT2, SIRT3, and SIRT5

  2020cites this paper
• Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.

  2020cites this paper
• Sirtuin 1 Inhibiting Thiocyanates (S1th)—A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases

  2020cites this paper
• SIRT2 deficiency prevents age-related bone loss in rats by inhibiting osteoclastogenesis.

  2019cites this paper
• The compound 33i,a new sirt2 inhibitor, as a potential treatment for Alzheimer's disease

  2019cites this paper
• New SIRT2 inhibitors: Histidine-based bleomycin spin-off.

  2019cites this paper
• Antiproliferative S-Trityl-l-Cysteine -Derived Compounds as SIRT2 Inhibitors: Repurposing and Solubility Enhancement

  2019cites this paper